Cargando…
Monitoring of COVID-19-Associated Coagulopathy and Anticoagulation with Thromboelastometry
INTRODUCTION: Thrombosis occurs frequently in COVID-19. While the exact mechanism is unclear, 3 processes seem to play important roles in sepsis-related thrombosis and mortality: tissue factor expression on circulating monocytes and microparticles, hypercoagulability (increased clot firmness), and h...
Autores principales: | Katz, Daniel, Maher, Patrick, Getrajdman, Chloe, Hamburger, Joshua, Zhao, Shan, Madek, Jonathan, Bhatt, Himani, Levin, Matthew, Görlinger, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger GmbH
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018202/ https://www.ncbi.nlm.nih.gov/pubmed/34177421 http://dx.doi.org/10.1159/000514486 |
Ejemplares similares
-
4402 The effects of hemodilution in vitro on coagulation in term parturients using thromboelastometry
por: Getrajdman, Chloe, et al.
Publicado: (2020) -
82 Heparinase-Native Thromboelastometry Detects Hypercoagulability in COVID-19 Disease
por: Maher, P.J., et al.
Publicado: (2021) -
“In Less than No Time”: Feasibility of Rotational Thromboelastometry to Detect Anticoagulant Drugs Activity and to Guide Reversal Therapy
por: Pavoni, Vittorio, et al.
Publicado: (2022) -
Point-of-care detection and differentiation of anticoagulant therapy - development of thromboelastometry-guided decision-making support algorithms
por: Schäfer, Simon T., et al.
Publicado: (2021) -
Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry – a prospectively controlled randomized double-blind clinical trial
por: Beiderlinden, Martin, et al.
Publicado: (2018)